Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on the Optimal Strategy for Acute-on-chronic Liver Failure Combined With Traditional Chinese and Modern Medicine: a Multi-center, Randomized and Controlled Study

NCT03577938 is registered in ClinicalTrials.gov with Beijing 302 Hospital as lead sponsor.

NCT NCT03577938
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03577938 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on the Optimal Strategy for Acute-on-chronic Liver Failure Combined With Traditional Chinese and Modern Medicine: a Multi-center, Randomized and Controlled Study
Lead sponsor
Beijing 302 Hospital
Phase
Not applicable
Overall status
Completed
Start date
January 10, 2019
Completion date
June 30, 2021
Enrollment
516 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

acute on chronic liver failure, hepatitis b, traditional chinese medicine